Metabolomic Diagnostics
Diagnostic assay that predicts preeclampsia in pregnancy
Metabolomic Diagnostics is active in the diagnostics space based in Cork, Ireland, founded in 2011.
Profile
Metabolomic Diagnostics offers a revolutionary blood test to be administered at 15 weeks into a pregnancy that can accurately predict the risk that a woman will develop pre-eclampsia later in pregnancy. A combination of metabolites in the blood is measured and the results, along with certain clinical data, are fed into a classification algorithm, which extrapolates the results. This information will allow clinicians to tailor specific medical care to patients who are at higher risk of developing pre-eclampsia.
Metabolomic Diagnostics is positioned in diagnostics, a segment that rewards a clear, focused offering.
Cork, Ireland is where the company is located.
It is recorded at the Participant stage.
Its team size is recorded as 2-10 employees.
It has disclosed roughly $3.2M in funding.
| Sector | Diagnostics |
|---|---|
| Headquarters | Cork, Ireland |
| Country | Ireland |
| Founded | 2011 |
| Employees | 2-10 |
| Stage | Participant |
| Total funding | $3,150,000 |
Website: metabolomicdiagnostics.com
Create a free account